317 related articles for article (PubMed ID: 24564226)
1. Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.
Chuang YC; Cheng CY; Sheng WH; Sun HY; Wang JT; Chen YC; Chang SC
BMC Infect Dis; 2014 Feb; 14():102. PubMed ID: 24564226
[TBL] [Abstract][Full Text] [Related]
2. Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
Cheng A; Chuang YC; Sun HY; Sheng WH; Yang CJ; Liao CH; Hsueh PR; Yang JL; Shen NJ; Wang JT; Hung CC; Chen YC; Chang SC
Crit Care Med; 2015 Jun; 43(6):1194-204. PubMed ID: 25793437
[TBL] [Abstract][Full Text] [Related]
3. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
[TBL] [Abstract][Full Text] [Related]
4. The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii.
Ye JJ; Lin HS; Kuo AJ; Leu HS; Chiang PC; Huang CT; Lee MH
J Infect; 2011 Nov; 63(5):351-61. PubMed ID: 21846481
[TBL] [Abstract][Full Text] [Related]
5. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii.
Kwon SH; Ahn HL; Han OY; La HO
Biol Pharm Bull; 2014; 37(3):340-6. PubMed ID: 24583855
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection.
Shin JA; Chang YS; Kim HJ; Kim SK; Chang J; Ahn CM; Byun MK
Yonsei Med J; 2012 Sep; 53(5):974-84. PubMed ID: 22869481
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of tigecycline in the treatment of nosocomial infection in a hospital in Taiwan.
Wu MT; Chen HY; Ou TY; Kuo LN; Cheng KJ; Lee WS
Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1030-6. PubMed ID: 25345432
[TBL] [Abstract][Full Text] [Related]
12. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
Cakirlar FK; Ciftci IH; Gonullu N
Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients.
Kuo SC; Wang FD; Fung CP; Chen LY; Chen SJ; Chiang MC; Hsu SF; Liu CY
J Microbiol Immunol Infect; 2011 Feb; 44(1):45-51. PubMed ID: 21531352
[TBL] [Abstract][Full Text] [Related]
14. Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin.
Chen YM; Fang WF; Kao HC; Chen HC; Tsai YC; Shen LS; Li CL; Chang HC; Huang KT; Lin MC; Wang CC; Chao TY
Biomed J; 2014; 37(5):314-20. PubMed ID: 25179700
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
Jean SS; Hsieh TC; Lee WS; Hsueh PR; Hsu CW; Lam C
Medicine (Baltimore); 2018 Sep; 97(39):e12278. PubMed ID: 30278498
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Cefiderocol, a Novel Siderophore Cephalosporin, against Multidrug Resistant Acinetobacter baumannii Clinical Isolates in Japan.
Kimura Y; Hatayama N; Sato Y; Nishida S; Yoshino Y
Jpn J Infect Dis; 2024 May; 77(3):178-181. PubMed ID: 38296540
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.
Kengkla K; Kongpakwattana K; Saokaew S; Apisarnthanarak A; Chaiyakunapruk N
J Antimicrob Chemother; 2018 Jan; 73(1):22-32. PubMed ID: 29069421
[TBL] [Abstract][Full Text] [Related]
18. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline.
Kooli I; Brahim HB; Kilani M; Gannouni C; Aouam A; Toumi A; Loussaief C; Hattab MN; Chakroun M
J Glob Antimicrob Resist; 2016 Jun; 5():62-3. PubMed ID: 27436468
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]